Published in Neurology on December 14, 2010
Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Front Neurol (2014) 1.27
Potentially relevant incidental findings on research whole-body MRI in the general adult population: frequencies and management. Eur Radiol (2012) 1.13
Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review. J Cereb Blood Flow Metab (2013) 1.03
Cerebral microbleeds: overview and implications in cognitive impairment. Alzheimers Res Ther (2014) 1.02
Diabetes, markers of brain pathology and cognitive function: the Age, Gene/Environment Susceptibility-Reykjavik Study. Ann Neurol (2014) 1.01
Psychosocial consequences and severity of disclosed incidental findings from whole-body MRI in a general population study. Eur Radiol (2012) 0.97
Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med (2014) 0.91
The influence of subclinical cardiovascular disease and related risk factors on cognition in type 2 diabetes mellitus: The DHS-Mind study. J Diabetes Complications (2013) 0.91
Cardiac hemodynamics are linked with structural and functional features of brain aging: the age, gene/environment susceptibility (AGES)-Reykjavik Study. J Am Heart Assoc (2015) 0.90
Ischemic brain injury in cerebral amyloid angiopathy. J Cereb Blood Flow Metab (2016) 0.89
Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities. J Diabetes Investig (2016) 0.87
Adverse vascular risk is related to cognitive decline in older adults. J Alzheimers Dis (2015) 0.87
Cerebral Microbleeds, CSF p-Tau, and Cognitive Decline: Significance of Anatomic Distribution. AJNR Am J Neuroradiol (2015) 0.87
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension (2016) 0.87
Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals. Alzheimers Dement (2016) 0.84
Brain Volume as an Integrated Marker for the Risk of Death in a Community-Based Sample: Age Gene/Environment Susceptibility-Reykjavik Study. J Gerontol A Biol Sci Med Sci (2014) 0.83
Cerebral microbleeds in a multiethnic elderly community: demographic and clinical correlates. J Neurol Sci (2014) 0.82
Cerebral Microbleeds and White Matter Hyperintensities in Cognitively Healthy Elderly: A Cross-Sectional Cohort Study Evaluating the Effect of Arterial Stiffness. Cerebrovasc Dis Extra (2015) 0.82
Is apolipoprotein E4 an important risk factor for vascular dementia? Int J Clin Exp Pathol (2014) 0.81
Brain regulation of thrombosis and hemostasis: from theory to practice. Stroke (2013) 0.80
Retinopathy and risk of dementia: the Rotterdam Study. Neurology (2012) 0.80
Retinal vascular fractals and cognitive impairment. Dement Geriatr Cogn Dis Extra (2014) 0.80
Cerebral microbleeds are associated with worse cognitive function in the nondemented elderly with small vessel disease. Cerebrovasc Dis Extra (2014) 0.79
A meta-analysis of association between cerebral microbleeds and cognitive impairment. Med Sci Monit (2014) 0.78
Carotid arterial stiffness and risk of incident cerebral microbleeds in older people: the Age, Gene/Environment Susceptibility (AGES)-Reykjavik study. Arterioscler Thromb Vasc Biol (2015) 0.78
Retinal vascular fractal dimension, childhood IQ, and cognitive ability in old age: the Lothian Birth Cohort Study 1936. PLoS One (2015) 0.78
Cerebral microbleeds and cognitive decline in a hemodialysis patient: Case report and review of literature. Hemodial Int (2014) 0.77
Serum uric acid levels and cerebral microbleeds in patients with acute ischemic stroke. PLoS One (2013) 0.77
Associations between recent severe hypoglycemia, retinal vessel diameters, and cognition in adults with type 1 diabetes. J Diabetes Complications (2016) 0.75
Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases. Am J Physiol Heart Circ Physiol (2016) 0.75
The application of retinal fundus camera imaging in dementia: A systematic review. Alzheimers Dement (Amst) (2016) 0.75
The clinical significance of brain microbleeds in patients with Alzheimer's disease: Preliminary study. Ann Indian Acad Neurol (2016) 0.75
Impact of whole-body MRI in a general population study. Eur J Epidemiol (2015) 0.75
Relationship between radiation dose and microbleed formation in patients with malignant glioma. Radiat Oncol (2017) 0.75
The significant effects of cerebral microbleeds on cognitive dysfunction: An updated meta-analysis. PLoS One (2017) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol (2007) 7.06
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA (2002) 6.18
Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol (2009) 6.02
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology (1992) 5.95
The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol (2005) 4.54
Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology (2008) 3.76
Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol (1999) 3.67
Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain (2005) 3.34
Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol (1985) (2008) 3.25
Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA (2002) 2.72
Detection of age-related macular degeneration using a nonmydriatic digital camera and a standard film fundus camera. Arch Ophthalmol (2004) 2.67
Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol (2009) 2.67
Migraine headache in middle age and late-life brain infarcts. JAMA (2009) 2.65
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology (2002) 2.42
Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology (2006) 2.38
Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry (2004) 2.32
Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain (2004) 2.07
Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol (2009) 2.01
Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry (2008) 1.99
Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke (2004) 1.96
Cerebral infarcts and cognitive performance: importance of location and number of infarcts. Stroke (2009) 1.93
Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol (2010) 1.78
Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke (2002) 1.77
Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility--Reykjavik study. Am J Epidemiol (2008) 1.66
Retinal and cerebral microvascular signs and diabetes: the age, gene/environment susceptibility-Reykjavik study. Diabetes (2008) 1.62
Associations between findings on cranial magnetic resonance imaging and retinal photography in the elderly: the Cardiovascular Health Study. Am J Epidemiol (2006) 1.56
Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study. Neurology (2009) 1.40
Retinal microvascular signs, cognitive function, and dementia in older persons: the Cardiovascular Health Study. Stroke (2007) 1.38
White matter lesions and cognitive performance: the role of cognitively complex leisure activity. J Gerontol A Biol Sci Med Sci (2008) 1.33
Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci (2004) 1.18
Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology (2005) 1.17
MRI correlates of cognitive decline in CADASIL: a 7-year follow-up study. Neurology (2009) 1.10
Retinal microvascular signs and cognitive impairment. J Am Geriatr Soc (2009) 1.09
Microvascular lesions in the brain and retina: The age, gene/environment susceptibility-Reykjavik study. Ann Neurol (2009) 0.96
Cerebral microbleeds: clinical and pathophysiological significance. J Neuroimaging (2007) 0.94
On the Oregon trail: rationing health care. BMJ (1991) 20.63
Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet (1999) 11.79
Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc (2000) 10.19
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05
Elevated C-reactive protein levels in overweight and obese adults. JAMA (1999) 9.94
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1984) 9.28
Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med (1995) 8.89
Role of brain insulin receptor in control of body weight and reproduction. Science (2000) 8.14
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care (1992) 7.69
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol (1984) 7.68
Milburn's vision of a new NHS. Adopting the missionary position. BMJ (2001) 7.31
Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int (1998) 7.14
Two views on the Griffiths report. The mobilisation of consent versus the management of conflict: decoding the Griffiths report. Br Med J (Clin Res Ed) (1983) 6.16
Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology (1999) 6.07
Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin. The Epidemiology of Hearing Loss Study. Am J Epidemiol (1998) 6.04
The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology (1984) 5.91
Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res (1997) 5.69
Explaining outputs of primary health care: population and practice factors. BMJ (1991) 5.61
Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature (1995) 5.51
Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol (1985) (2001) 5.35
Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology (1992) 5.35
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc (1999) 4.84
Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev (1999) 4.75
Variations in budgets of fundholding practices. BMJ (1991) 4.71
Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron (2001) 4.62
The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making (1993) 4.46
Genome sequence, comparative analysis, and population genetics of the domestic horse. Science (2009) 4.41
Essential role for TrkB receptors in hippocampus-mediated learning. Neuron (1999) 4.20
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
The 14-year incidence of visual loss in a diabetic population. Ophthalmology (1998) 4.08
Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol (2000) 3.94
Cigarette smoking and hearing loss: the epidemiology of hearing loss study. JAMA (1998) 3.86
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol (1998) 3.75
Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature (1994) 3.73
Equity and the NHS: self-reported morbidity, access, and primary care. Br Med J (1980) 3.72
Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology (1990) 3.66
Visual impairment in diabetes. Ophthalmology (1984) 3.64
Warning signals from Oregon. BMJ (1992) 3.58
Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell (2000) 3.54
Towards a new pluralism. Health Policy (1987) 3.47
Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci (2000) 3.45
Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond) (2005) 3.41
Diabetic retinopathy. Diabetes Care (1998) 3.39
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest (1982) 3.33
The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol (2001) 3.31
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology (2010) 3.31
Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet (2001) 3.28
Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology (1985) 3.20
Rationing in practice: the case of in vitro fertilisation. BMJ (1993) 3.20
Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia (2005) 3.20
Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell (1996) 3.19
CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology (2003) 3.18
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology (2007) 3.12
Priorities and rationing: pragmatism or principles? BMJ (1995) 3.09
An alternative method of grading diabetic retinopathy. Ophthalmology (1986) 3.05
trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell (1991) 2.97
Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care (1998) 2.97
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol (1999) 2.92
Ten-year incidence of visual loss in a diabetic population. Ophthalmology (1994) 2.91
Cause-specific mortality in a population-based study of diabetes. Am J Public Health (1991) 2.89
Low prevalence of hearing aid use among older adults with hearing loss: the Epidemiology of Hearing Loss Study. J Am Geriatr Soc (1998) 2.88
Cardiovascular risk factors and migraine: the GEM population-based study. Neurology (2005) 2.86
Validity of fan-beam dual-energy X-ray absorptiometry for measuring fat-free mass and leg muscle mass. Health, Aging, and Body Composition Study--Dual-Energy X-ray Absorptiometry and Body Composition Working Group. J Appl Physiol (1985) (1999) 2.81
Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature (1999) 2.80
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
The politics of change. BMJ (1991) 2.70
Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology (1992) 2.68
Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67
Puzzling out priorities. Why we must acknowledge that rationing is a political process. BMJ (1998) 2.65
Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study. Eur Heart J (2002) 2.60
Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci (1992) 2.55
Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int (2009) 2.53
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
Low cholesterol concentrations and severe depressive symptoms in elderly people. BMJ (1994) 2.51
Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol (2001) 2.51
Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study. Ophthalmology (1998) 2.50
Is the English NHS underfunded? BMJ (1999) 2.47
Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Association of NIDDM and hearing loss. Diabetes Care (1998) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res (1996) 2.43
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology (2002) 2.42
NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41
The GlideScope Video Laryngoscope: randomized clinical trial in 200 patients. Br J Anaesth (2004) 2.41
Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science (1997) 2.40
Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol (1994) 2.39
Controlling the gatekeepers: the accountability of general practitioners. J R Coll Gen Pract (1986) 2.39
Refractive status in the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci (1994) 2.36
From evidence-based medicine to evidence-based policy? J Health Serv Res Policy (2000) 2.36
Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA (1999) 2.35